master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
Published 1 year ago • 160 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
1:34
master subgroup analysis: quadruplet induction, autosct & treatment cessation in ndmm patients ≥70
-
2:17
extended follow-up of the master trial
-
9:57
quadruplet therapies for treating mm: the current evidence and the findings of a phase ii trial
-
1:42
immune profiling & mrd negativity of ndmm treated with quadruplet induction autosct: milestone trial
-
5:33
syaraf terjepit penyebab migrain langsung sembuh🔥‼️ #masterjoetherapy #bonesetting #yt
-
4:04
the future of myeloma treatment and the possibility of cure
-
1:46:07
hematology lecture
-
1:00
quadruplet induction therapy in newly diagnosed high-risk myeloma
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:37
evidence supporting mrd-guided treatment breaks in mm
-
1:16
an insight into the beat aml trial and the value of precision medicine
-
1:06
derive trial update: did vs dvd in newly diagnosed mm
-
2:12
refine: phase ii study of navitoclax ruxolitinib in jak inhibitor-naive patients with mf
-
1:30
real-world treatment patterns in third-line therapy for r/r myeloma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
3:25
final analysis of centaurus: daratumumab monotherapy for smm
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space